Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal DNA in maternal plasma.

Y M Lo1

  • 1Department of Chemical Pathology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories. loym@cuhk.edu.hk

Annals of the New York Academy of Sciences
|May 20, 2000
PubMed
Summary

Cell-free fetal DNA in maternal plasma offers a novel, accessible source for prenatal diagnosis. Elevated levels may indicate pregnancy complications like preeclampsia, impacting diagnostic and pathophysiologic understanding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications.

The Journal of pathology·2011
Same author

Introduction to the polymerase chain reaction.

Methods in molecular medicine·2011
Same author

Setting up a PCR laboratory.

Methods in molecular medicine·2011
Same author

Amplification from archival materials.

Methods in molecular medicine·2011
Same author

The amplification refractory mutation system.

Methods in molecular medicine·2011
Same author

Artificial Restriction Fragment Length Polymorphism (A-RFLP) Analysis.

Methods in molecular medicine·2011

Area of Science:

  • Genetics
  • Obstetrics
  • Molecular Biology

Background:

  • Cell-free fetal DNA (cfDNA) is detectable in maternal plasma and serum.
  • This cfDNA provides an accessible source of fetal genetic material for prenatal diagnosis.
  • cfDNA concentrations are higher than fetal nucleated cells in maternal blood.

Purpose of the Study:

  • To explore the diagnostic applications of cfDNA in prenatal testing.
  • To investigate the relationship between cfDNA levels and pregnancy complications.
  • To understand the production and clearance mechanisms of cfDNA.

Main Methods:

  • Analysis of cfDNA in maternal plasma and serum.
  • Monitoring cfDNA concentration throughout gestation.
  • Correlating cfDNA levels with pregnancy outcomes and complications.

Main Results:

  • Prenatal diagnostic applications include sex-linked disorders and RhD status.
  • cfDNA concentration increases with gestational age, rising sharply near term.
  • Abnormally high cfDNA levels are associated with preeclampsia and preterm labor.

Conclusions:

  • Maternal plasma cfDNA is a valuable tool for prenatal diagnosis.
  • cfDNA levels have potential diagnostic and pathophysiologic implications for pregnancy complications.
  • Further research into cfDNA mechanisms will enhance understanding of the fetomaternal relationship.

Related Experiment Videos